Signaling pathways
-
BA3267 SFI003Summary: SFI003 is a novel inhibitor. - BA3268 TH-6Summary: TH-6 was a potent inhibitor with 0.115, 0.135, 0.242, 0.138, and 2.120 μM for HDAC1, HDAC2, HDAC3, HDAC6, and HDAC8, respectively.
- BA3269 VPC-70063Summary: VPC-70063 is a potent inhibitor.
- BA3270 Z-LLNle-CHOSummary: Z-LLNle-CHO (Z-Leu-Leu-Nle-CHO) is an inhibitor I.
- BA3271 WJ-39Summary: WJ-39 is an aldose reductase inhibitor with oral activity.
- BA3272 6-DehydrogingerdioneSummary: 6-Dehydrogingerdione mediates the increase in DR5 via reactive oxygen species.
- BA3273 3-HydroxyterphenyllinSummary: 3-Hydroxyterphenyllin is the metabolite.
- BA3274 DCZ3301Summary: DCZ3301 is a potent aryl guanidine inhibitor.
- BA3276 Thalidomide-NH-PEG3-NH-BocSummary: An E3 ligase ligand concatenated with a linker.
- BA3277 DehydroleucodineSummary: Dehydroleucodine is a sesquiterpene lactone isolated from...